Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo

References

• Desselberger U, Huppertz HI. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J Infect Dis 2011; 203:188 - 95; http://dx.doi.org/10.1093/infdis/jiq031; PMID: 21288818
   PubMed Web of Science ®Google Scholar
• Estes MK, Kapikian A. Rotaviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, eds. Fields Virology, 5th Edn. Philadelphia: Lippincott Williams & Wilkins, 2007:1917–74.
   Google Scholar
• Ludert JE, Feng N, Yu JH, Broome RL, Hoshino Y, Greenberg HB. Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol 1996; 70:487 - 93; PMID: 8523562
   PubMed Web of Science ®Google Scholar
• Graham KL, Halasz P, Tan Y, Hewish MJ, Takada Y, Mackow ER, Robinson MK, Coulson BS. Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol 2003; 77:9969 - 78; http://dx.doi.org/10.1128/JVI.77.18.9969-9978.2003; PMID: 12941907
   PubMedGoogle Scholar
• Matthijnssens J, Otto PH, Ciarlet M, Desselberger U, Van Ranst M, Johne R. VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol 2012; 157:1177 - 82; http://dx.doi.org/10.1007/s00705-012-1273-3; PMID: 22430951
   PubMed Web of Science ®Google Scholar
• Tang B, Gilbert JM, Matsui SM, Greenberg HB. Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis. Virology 1997; 237:89 - 96; http://dx.doi.org/10.1006/viro.1997.8762; PMID: 9344910
   PubMed Web of Science ®Google Scholar
• Estes MK, Crawford SE, Penaranda ME, Petrie BL, Burns JW, Chan WK, Ericson B, Smith GE, Summers MD. Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. J Virol 1987; 61:1488 - 94; PMID: 3033276
   PubMed Web of Science ®Google Scholar
• Svensson L, Sheshberadaran H, Vene S, Norrby E, Grandien M, Wadell G. Serum antibody responses to individual viral polypeptides in human rotavirus infections. J Gen Virol 1987; 68:643 - 51; http://dx.doi.org/10.1099/0022-1317-68-3-643; PMID: 3029295
   PubMed Web of Science ®Google Scholar
• Svensson L, Sheshberadaran H, Vesikari T, Norrby E, Wadell G. Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1). J Gen Virol 1987; 68:1993 - 9; http://dx.doi.org/10.1099/0022-1317-68-7-1993; PMID: 3037019
   PubMed Web of Science ®Google Scholar
• Ishida S, Feng N, Tang B, Gilbert JM, Greenberg HB. Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. J Clin Microbiol 1996; 34:1694 - 700; PMID: 8784572
   PubMed Web of Science ®Google Scholar
• Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006; 24:2718 - 31; http://dx.doi.org/10.1016/j.vaccine.2005.12.048; PMID: 16446014
   PubMed Web of Science ®Google Scholar
• Offit PA, Blavat G. Identification of the two rotavirus genes determining neutralization specificities. J Virol 1986; 57:376 - 8; PMID: 3001359
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al, Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11 - 22; http://dx.doi.org/10.1056/NEJMoa052434; PMID: 16394298
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al, Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23 - 33; http://dx.doi.org/10.1056/NEJMoa052664; PMID: 16394299
   PubMed Web of Science ®Google Scholar
• Block SL, Vesikari T, Goveia MG, Rivers SB, Adeyi BA, Dallas MJ, Bauder J, Boslego JW, Heaton PM, Pentavalent Rotavirus Vaccine Dose Confirmation Efficacy Study Group. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Pediatrics 2007; 119:11 - 8; http://dx.doi.org/10.1542/peds.2006-2058; PMID: 17200266
   PubMed Web of Science ®Google Scholar
• Vesikari T. Rotavirus vaccination: a concise review. Clin Microbiol Infect 2012; 18:Suppl 5 57 - 63; http://dx.doi.org/10.1111/j.1469-0691.2012.03981.x; PMID: 22882248
   PubMed Web of Science ®Google Scholar
• McNeal MM, Rae MN, Conner ME, Ward RL. Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21. Virology 1998; 243:158 - 66; http://dx.doi.org/10.1006/viro.1998.9060; PMID: 9527925
   PubMed Web of Science ®Google Scholar
• McNeal MM, Rae MN, Bean JA, Ward RL. Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol 1999; 73:7565 - 73; PMID: 10438846
   PubMed Web of Science ®Google Scholar
• Ciarlet M, Crawford SE, Barone C, Bertolotti-Ciarlet A, Ramig RF, Estes MK, Conner ME. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J Virol 1998; 72:9233 - 46; PMID: 9765471
   PubMed Web of Science ®Google Scholar
• O’Neal CM, Crawford SE, Estes MK, Conner ME. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol 1997; 71:8707 - 17; PMID: 9343229
   PubMed Web of Science ®Google Scholar
• Bertolotti-Ciarlet A, Ciarlet M, Crawford SE, Conner ME, Estes MK. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 2003; 21:3885 - 900; http://dx.doi.org/10.1016/S0264-410X(03)00308-6; PMID: 12922123
   PubMed Web of Science ®Google Scholar
• Choi AH, Basu M, McNeal MM, Clements JD, Ward RL. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol 1999; 73:7574 - 81; PMID: 10438847
   PubMed Web of Science ®Google Scholar
• Choi AH, McNeal MM, Basu M, Flint JA, Stone SC, Clements JD, Bean JA, Poe SA, VanCott JL, Ward RL. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine 2002; 20:3310 - 21; http://dx.doi.org/10.1016/S0264-410X(02)00315-8; PMID: 12213401
   PubMed Web of Science ®Google Scholar
• Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB, Wang S, Robinson HL. Protection against rotavirus infections by DNA vaccination. J Infect Dis 1996; 174:Suppl 1 S93 - 7; http://dx.doi.org/10.1093/infdis/174.Supplement_1.S93; PMID: 8752297
   PubMed Web of Science ®Google Scholar
• Chen SC, Jones DH, Fynan EF, Farrar GH, Clegg JC, Greenberg HB, Herrmann JE. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol 1998; 72:5757 - 61; PMID: 9621034
   PubMed Web of Science ®Google Scholar
• Yuan L, Geyer A, Hodgins DC, Fan Z, Qian Y, Chang KO, Crawford SE, Parreño V, Ward LA, Estes MK, et al. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs. J Virol 2000; 74:8843 - 53; http://dx.doi.org/10.1128/JVI.74.19.8843-8853.2000; PMID: 10982326
   PubMed Web of Science ®Google Scholar
• Lee S, Belitsky BR, Brinker JP, Kerstein KO, Brown DW, Clements JD, Keusch GT, Tzipori S, Sonenshein AL, Herrmann JE. Development of a Bacillus subtilis-based rotavirus vaccine. Clin Vaccine Immunol 2010; 17:1647 - 55; http://dx.doi.org/10.1128/CVI.00135-10; PMID: 20810679
   PubMed Web of Science ®Google Scholar
• Zhou H, Guo L, Wang M, Qu J, Zhao Z, Wang J, Hung T. Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice. Virol J 2011; 8:3; http://dx.doi.org/10.1186/1743-422X-8-3; PMID: 21205330
   PubMed Web of Science ®Google Scholar
• Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996; 272:104 - 7; http://dx.doi.org/10.1126/science.272.5258.104; PMID: 8600516
   PubMed Web of Science ®Google Scholar
• Schwartz-Cornil I, Benureau Y, Greenberg H, Hendrickson BA, Cohen J. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J Virol 2002; 76:8110 - 7; http://dx.doi.org/10.1128/JVI.76.16.8110-8117.2002; PMID: 12134016
   PubMed Web of Science ®Google Scholar
• Feng N, Lawton JA, Gilbert J, Kuklin N, Vo P, Prasad BV, Greenberg HB. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest 2002; 109:1203 - 13; http://dx.doi.org/10.1172/JCI14397; PMID: 11994409
   PubMed Web of Science ®Google Scholar
• Corthésy B, Benureau Y, Perrier C, Fourgeux C, Parez N, Greenberg H, Schwartz-Cornil I. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol 2006; 80:10692 - 9; http://dx.doi.org/10.1128/JVI.00927-06; PMID: 16956954
   PubMed Web of Science ®Google Scholar
• Aiyegbo MS, Sapparapu G, Spiller BW, Eli IM, Williams DR, Kim R, Lee DE, Liu T, Li S, Woods VL Jr., et al. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PLoS One 2013; 8:e61101; http://dx.doi.org/10.1371/journal.pone.0061101; PMID: 23671563
   PubMed Web of Science ®Google Scholar
• Gualtero DF, Guzmán F, Acosta O, Guerrero CA. Amino acid domains 280-297 of VP6 and 531-554 of VP4 are implicated in heat shock cognate protein hsc70-mediated rotavirus infection. Arch Virol 2007; 152:2183 - 96; http://dx.doi.org/10.1007/s00705-007-1055-5; PMID: 17876681
   PubMed Web of Science ®Google Scholar
• Garaicoechea L, Olichon A, Marcoppido G, Wigdorovitz A, Mozgovoj M, Saif L, Surrey T, Parreño V. Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J Virol 2008; 82:9753 - 64; http://dx.doi.org/10.1128/JVI.00436-08; PMID: 18632867
   PubMed Web of Science ®Google Scholar
• Aladin F, Einerhand AW, Bouma J, Bezemer S, Hermans P, Wolvers D, Bellamy K, Frenken LG, Gray J, Iturriza-Gómara M. In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PLoS One 2012; 7:e32949; http://dx.doi.org/10.1371/journal.pone.0032949; PMID: 22403728
   PubMed Web of Science ®Google Scholar
• Vega CG, Bok M, Vlasova AN, Chattha KS, Gómez-Sebastián S, Nuñez C, Alvarado C, Lasa R, Escribano JM, Garaicoechea LL, et al. Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea. PLoS Pathog 2013; 9:e1003334; http://dx.doi.org/10.1371/journal.ppat.1003334; PMID: 23658521
   PubMed Web of Science ®Google Scholar
• Knowlton DR, Spector DM, Ward RL. Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods 1991; 33:127 - 34; http://dx.doi.org/10.1016/0166-0934(91)90013-P; PMID: 1658027
   PubMed Web of Science ®Google Scholar
• Ward RL, Kapikian AZ, Goldberg KM, Knowlton DR, Watson MW, Rappaport R. Serum rotavirus neutralizing-antibody titers compared by plaque reduction and enzyme-linked immunosorbent assay-based neutralization assays. J Clin Microbiol 1996; 34:983 - 5; PMID: 8815124
   PubMed Web of Science ®Google Scholar
• Ruggeri FM, Johansen K, Basile G, Kraehenbuhl JP, Svensson L. Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol 1998; 72:2708 - 14; PMID: 9525588
   PubMed Web of Science ®Google Scholar
• Blazevic V, Lappalainen S, Nurminen K, Huhti L, Vesikari T. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine 2011; 29:8126 - 33; http://dx.doi.org/10.1016/j.vaccine.2011.08.026; PMID: 21854823
   PubMed Web of Science ®Google Scholar
• Vesikari T, Blazevic V, Nurminen K, Huhti L, Lappalainen S, Jokela E. Norovirus capsid and rotavirus VP6 protein for use as combined vaccine. Finnish patent 122520, 15 March 2012.
   Google Scholar
• Tamminen K, Lappalainen S, Huhti L, Vesikari T, Blazevic V. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One 2013; 8:e70409; http://dx.doi.org/10.1371/journal.pone.0070409; PMID: 23922988
   PubMed Web of Science ®Google Scholar
• Guerrero RA, Ball JM, Krater SS, Pacheco SE, Clements JD, Estes MK. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol 2001; 75:9713 - 22; http://dx.doi.org/10.1128/JVI.75.20.9713-9722.2001; PMID: 11559804
   PubMed Web of Science ®Google Scholar
• Amuguni JH, Lee S, Kerstein KO, Brown DW, Belitsky BR, Herrmann JE, Keusch GT, Sonenshein AL, Tzipori S. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice. Vaccine 2011; 29:4778 - 84; http://dx.doi.org/10.1016/j.vaccine.2011.04.083; PMID: 21565244
   PubMed Web of Science ®Google Scholar
• Lappalainen S, Tamminen K, Vesikari T, Blazevic V. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum Vaccin Immunother 2013; 9:1991 - 2001; http://dx.doi.org/10.4161/hv.25249; PMID: 23777748
   PubMed Web of Science ®Google Scholar
• Angel J, Franco MA, Greenberg HB. Rotavirus immune responses and correlates of protection. Curr Opin Virol 2012; 2:419 - 25; http://dx.doi.org/10.1016/j.coviro.2012.05.003; PMID: 22677178
   PubMed Web of Science ®Google Scholar
• Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis 2013; 208:284 - 94; http://dx.doi.org/10.1093/infdis/jit166; PMID: 23596320
   PubMed Web of Science ®Google Scholar
• Blutt SE, Conner ME. The Gastrointestinal Frontier: IgA and Viruses. Front Immunol 2013; 4:402; http://dx.doi.org/10.3389/fimmu.2013.00402; PMID: 24348474
   PubMed Web of Science ®Google Scholar
• Cheuvart B, Neuzil KM, Steele AD, Cunliffe N, Madhi SA, Karkada N, Han HH, Vinals C. Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine. Hum Vaccin Immunother 2013; 10:58 - 64; http://dx.doi.org/10.4161/hv.27097; PMID: 24240068
   PubMed Web of Science ®Google Scholar
• Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A 1992; 89:6901 - 5; http://dx.doi.org/10.1073/pnas.89.15.6901; PMID: 1323121
   PubMed Web of Science ®Google Scholar
• Tosser G, Delaunay T, Kohli E, Grosclaude J, Pothier P, Cohen J. Topology of bovine rotavirus (RF strain) VP6 epitopes by real-time biospecific interaction analysis. Virology 1994; 204:8 - 16; http://dx.doi.org/10.1006/viro.1994.1505; PMID: 7522377
   PubMed Web of Science ®Google Scholar
• Ward RL, McNeal MM, Sheridan JF. Development of an adult mouse model for studies on protection against rotavirus. J Virol 1990; 64:5070 - 5; PMID: 2168987
   PubMed Web of Science ®Google Scholar
• Pastor AR, Rodríguez-Limas WA, Contreras MA, Esquivel E, Esquivel-Guadarrama F, Ramírez OT, Palomares LA. The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice. Vaccine 2014; In press http://dx.doi.org/10.1016/j.vaccine.2014.02.018; PMID: 24583002
   PubMed Web of Science ®Google Scholar
• McNeal MM, Stone SC, Basu M, Bean JA, Clements JD, Hendrickson BA, Choi AH, Ward RL. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology 2006; 346:338 - 47; http://dx.doi.org/10.1016/j.virol.2005.11.016; PMID: 16375942
   PubMed Web of Science ®Google Scholar
• Tamminen K, Huhti L, Koho T, Lappalainen S, Hytönen VP, Vesikari T, Blazevic V. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology 2012; 135:89 - 99; http://dx.doi.org/10.1111/j.1365-2567.2011.03516.x; PMID: 22044070
   PubMed Web of Science ®Google Scholar
• DiStefano DJ, Gould SL, Munshi S, Robinson DK. Titration of human-bovine rotavirus reassortants using a tetrazolium-based colorimetric end-point dilution assay. J Virol Methods 1995; 55:199 - 208; http://dx.doi.org/10.1016/0166-0934(95)00057-2; PMID: 8537458
   PubMed Web of Science ®Google Scholar
• Pang XL, Joensuu J, Hoshino Y, Kapikian AZ, Vesikari T. Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis. J Clin Virol 1999; 13:9 - 16; http://dx.doi.org/10.1016/S1386-6532(98)00013-4; PMID: 10405887
   PubMed Web of Science ®Google Scholar
• Ward RL, Bernstein DI, Shukla R, Young EC, Sherwood JR, McNeal MM, Walker MC, Schiff GM. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis 1989; 159:79 - 88; http://dx.doi.org/10.1093/infdis/159.1.79; PMID: 2535868
   PubMed Web of Science ®Google Scholar
• Esquivel FR, Lopez S, Guitierrez-X L, Arias C. The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response. Arch Virol 2000; 145:813 - 25; http://dx.doi.org/10.1007/s007050050674; PMID: 10893159
   PubMed Web of Science ®Google Scholar